<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1052243361488264&amp;ev=PageView&amp;noscript=1">
Jonni-Moore

Jonni Moore, Ph.D.

Board Member

Dr. Jonni Moore has more than 25 years experience in laboratory medicine and research in cellular immunology. One of the world’s leading experts in flow cytometry, she is looked to as a thought leader in cutting-edge applications in this field. Most recently, her research activities have evolved along the path of technology development with a focus on complex technologies, in particular on high dimensional flow cytometry in a systems biology setting, or cytomics. She has published over 150 peer-reviewed manuscripts and is a frequent invited speaker on flow cytometry at national and international meetings. She is very active in the International Society for the Advancement of Cytometry leading the flow cytometry section of the new Cyto University, an online resource, being developed by this international organization.

Dr. Moore received her Ph.D. in Microbiology and Immunology from Thomas Jefferson University and joined the Department of Pathology and Laboratory Medicine at the University of Pennsylvania as a postdoctoral fellow, and was subsequently appointed to the faculty, where she has remained rising to the rank of full professor. She has served as Director of the Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource since 1991, a facility that has consistently been recognized as the largest and most comprehensive academic flow cytometry resource laboratory in the US winning the designation of exceptional from the National Cancer Institute of the NIH. She was appointed the first director of the Clinical Flow Cytometry Laboratory at the Hospital of the University of Pennsylvania and developed the first dedicated clinical flow cytometry rotation in pathology residency training programs and spends significant time educating physicians on the use of this technology in clinical medicine.

Dr. Jonni Moore’s many awards include being the recipient of the 2016 ICCS Wallace H. Coulter Award presented by the International Clinical Cytometry Society (ICCS). The Coulter award recognizes an individual from anywhere in the world for his or her lifetime contributions to the science, education and practice of Clinical Cytometry and is the highest honor in the field. The award is named after Wallace H. Coulter (1913-1998), a pioneer for innovations in diagnostic and investigative medicine.

Dr. Moore was also a co-founder of CytoVas, LLC, a cardiovascular diagnostics company founded through the PCI Ventures Program of the University of Pennsylvania. CytoVas has developed a flow cytometry based cardiovascular diagnostic, the Vascular Health Profile, which uses personalized cytomics to evaluate the health of a patient’s vascular system. This is the first-in-sector clinical flow cytometry test for cardiovascular disease.

JeanMarie Markham  Board Member
Frank Ricotta  Board Member